Valens GroWorks receives their ACMPR licence from Health Canada

Valens GroWorks (CSE:VGW) Vice President of Operations Chatel Popoff and their Head of Production Quinn Shiskin joined Steve Darling from Proactive Investors on Skype to talk about Valens receiving their access to cannabis for medical purposes regulations licence from Health Canada. They also shared details about the new emulsion technology called SoRSE and what is means for the company going forward.